Up-regulation of NEK2 by MicroRNA-128 Methylation is Associated with Poor Prognosis in Colorectal Cancer

[1]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[2]  K S Kosik,et al.  Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases , 2012, Oncogene.

[3]  B. Jiang,et al.  MiR-128 Inhibits Tumor Growth and Angiogenesis by Targeting p70S6K1 , 2012, PloS one.

[4]  J. Inazawa,et al.  miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. , 2011, Cancer research.

[5]  Wei-dong Li,et al.  Abnormal expression of Nek2 and β‐catenin in breast carcinoma: clinicopathological correlations , 2011, Histopathology.

[6]  F. Yu,et al.  Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5 , 2011, Clinical Cancer Research.

[7]  A. Fry,et al.  Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction , 2010, Nature Cell Biology.

[8]  M. Nagino,et al.  Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin , 2010, Cancer science.

[9]  Giuseppe Giannini,et al.  MiR‐128 up‐regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  M. Nagino,et al.  Nek2 as a novel molecular target for the treatment of breast carcinoma , 2009, Cancer science.

[11]  Agnieszka Bronisz,et al.  Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. , 2008, Cancer research.

[12]  Phang-lang Chen,et al.  Small molecule targeting the Hec1/Nek2 mitotic pathway suppresses tumor cell growth in culture and in animal. , 2008, Cancer research.

[13]  Masaaki Oda,et al.  QUMA: quantification tool for methylation analysis , 2008, Nucleic Acids Res..

[14]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[15]  M. Nagino,et al.  Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma. , 2007, Cancer research.

[16]  K. Mimori,et al.  Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin‐conjugating enzyme E2C gene expression , 2007, International journal of cancer.

[17]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[18]  Andrew M Fry,et al.  The Centrosomal Kinase Nek2 Displays Elevated Levels of Protein Expression in Human Breast Cancer , 2004, Cancer Research.

[19]  R. Muschel,et al.  Inhibition of Centrosome Separation after DNA Damage: A Role for Nek2 , 2004, Radiation research.

[20]  T. Grogan,et al.  Gene Expression Profile of Serial Samples of Transformed B-Cell Lymphomas , 2003, Laboratory Investigation.

[21]  A. Fry.  The Nek2 protein kinase: a novel regulator of centrosome structure , 2002, Oncogene.

[22]  P. Meraldi,et al.  A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators , 1998, The EMBO journal.